Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1599)	3/14/2006 2:05:51 PM
From: zeta1961	Read Replies (1) \| Respond to of 3722

out of my "buying range", You are so cheap when it comes to buying stocks..un problema que cada esposa debe tener-s-

To: Jibacoa who wrote (1599)	3/27/2006 10:36:55 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

RNAI opened with an upgap this morning. It was going up early in EHs & had a first minute volume of 180,666 apparently due to some short covering. The stock seems to be rising in sympathy with the news on ALNY which had an article published in Nature about the results of its RNAi targeting apoB lipoprotein. "Following administration of a single intravenous bolus dose at low dosages from 1.0-2.5 mg/kg, reductions were observed as early as 24 hours after treatment and lasted for at least 11 days." <g> The studies were done in primates in collaboration with Protiva Biotherapeutics & ANLY CEO said: "These data give us confidence that with further optimization of our systemic RNAi platform we can move a systemic RNAi therapeutic candidate into human clinical trials as early as the next 18-24 months," <g> As previously mentioned, RNAI stock still needs to close above its March 13 H of 7.39 before it can retest its March 3 H at 7.62 <g> Today it has already closed almost half of its initial upgap. I like RNAI's LTC & still hope that I will live long enough to see it trading somewhere in the 30s <G> bigcharts.marketwatch.com Bernard